ArticleFrontiers in immunology2025

Long-term follow-up of patients with relapsed/refractory multiple myeloma after BCMA CAR-T-cell therapy.

Yuanyuan Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.